ProQinase Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
62
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
1
ProQinase General Information
Description
Provider of contract research and drug discovery services in Germany. The company's offerings include recombinant target proteins, biochemical and cell-based assays, vivo tumor models in mice, protein kinases and preclinical testing services, enabling clients with cancer drug discovery projects to get custom-tailored services.
Contact Information
Website
www.proqinase.comCorporate Office
- Breisacher Street 117
- 79106 Freiburg
- Germany
Corporate Office
- Breisacher Street 117
- 79106 Freiburg
- Germany
ProQinase Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ProQinase Comparisons
Industry
Financing
Details
ProQinase Competitors (41)
One of ProQinase’s 41 competitors is Adaptimmune Therapeutics, a Formerly VC-backed company based in Abingdon, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| BPS Bioscience | Corporation | San Diego, CA | ||||
| Sygnature Discovery | Private Equity-Backed | Nottingham, United Kingdom | ||||
| etherna | Formerly VC-backed | Niel, Belgium | ||||
| TME Pharma | Formerly VC-backed | Berlin, Germany |
ProQinase Patents
ProQinase Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220073921-A1 | Aptamer and use of the aptamer in the diagnosis and treatment of cancer | Inactive | 21-Jan-2019 | ||
| EP-3583845-A1 | Mammary fat pad (mfp) tumor cell inoculation to avoid tumor ulceration | Inactive | 19-Jun-2018 | ||
| EP-2922857-A1 | Thioether derivatives as protein kinase inhibitors | Active | 20-Nov-2012 | ||
| EP-2922857-B1 | Thioether derivatives as protein kinase inhibitors | Inactive | 20-Nov-2012 | ||
| US-20150328219-A1 | Thioether derivatives as protein kinase inhibitors | Active | 20-Nov-2012 | A61K31/52 |
ProQinase Signals
ProQinase Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ProQinase Investments (1)
ProQinase’s most recent deal was a Joint Venture with Novithera. The deal was made on 24-Oct-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Novithera | 24-Oct-2016 | Joint Venture | Therapeutic Devices |
ProQinase Exits (1)
ProQinase’s most recent exit was on 24-Oct-2016 from Novithera. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Novithera | 24-Oct-2016 | Completed |
|
ProQinase Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Bioassay Labor für biologische Analytik | Heidelberg, Germany | 2002 |
ProQinase FAQs
-
When was ProQinase founded?
ProQinase was founded in 2001.
-
Where is ProQinase headquartered?
ProQinase is headquartered in Freiburg, Germany.
-
What is the size of ProQinase?
ProQinase has 62 total employees.
-
What industry is ProQinase in?
ProQinase’s primary industry is Drug Discovery.
-
Is ProQinase a private or public company?
ProQinase is a Private company.
-
What is ProQinase’s current revenue?
The current revenue for ProQinase is .
-
Who are ProQinase’s investors?
ChinaEquity Group and KTB Klinik für Tumorbiologie have invested in ProQinase.
-
Who are ProQinase’s competitors?
Adaptimmune Therapeutics, BPS Bioscience, Sygnature Discovery, etherna, and TME Pharma are some of the 41 competitors of ProQinase.
-
When was ProQinase acquired?
ProQinase was acquired on 04-Feb-2019.
-
Who acquired ProQinase?
ProQinase was acquired by Reaction Biology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process